Effects of antimicrobials on intestinal flora: Its changes with antibiotics used more in gastroenterology;Efectos de los antimicrobianos sobre la flora intestinal: Sus modificaciones con los antibióticos más utilizados en gastroenterología

Acta Gastroenterologica Latinoamericana

Volumn 33, Issue 1, 2003, Pages 37-41

  Vasen, W ^a,b   Fiorentino, Roxana ^a  

^a HOSPITAL DE GASTROENTEROLOGÍA DR CARLOS BONORINO UDAONDO   (Argentina)

^b Dpto 4   (Argentina)

Author keywords

Antibi ticos; Cefalosporinas; Claritromicina; Decontaminaci n intestinal selectiva; Imipenem flora intestinal; Metronodazol; Microflora intestinal; Quinolonas fluoradas

Indexed keywords

ANTIINFECTIVE AGENT;

DRUG EFFECT; HUMAN; INTESTINE; MICROBIOLOGY; REVIEW; STOMACH DISEASE;

ANTI-BACTERIAL AGENTS; HUMANS; INTESTINES; STOMACH DISEASES;

EID: 2142813999     PISSN: 03009033     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Mackowiak, PA: The normal microbial flora, Medical progress, The New Engl Journal of Med 1982;307(2):83-93.
2. Metchnikoff E:Sur la flore du corps humain.Manchester Lit Philos Soc. 1901;45:1-38.
3. Schottelius M: Die Bedeutung der Darmbakterien für die Ernährung. II Arch Hyg 1902;42:48-70.
4. Reyniers JA,Wagner M,Trexler PC,Luckey TD, Ervin RF, Gordon HA: A complete life -cicle in the "germen-free" Bantam chicken. Nature 1949;163:67-68.
5. HurstV:Colonization in the newborn.In:Maibach HI,Hildick-SmithG,eds.Skin bacteria and their role in the infections.New York:NcGraw-Hill, 1965:127-141.
6. Noble WC:Microbiology oy human skin. 2d ed. London: Lloyd-Luke Medical Books, 1981:362-365.
7. Long SS ,Swenson RM:Development of anaerobic fecal flora inhealthy newborn infants. J Pediatr 1977;91:298-301.
8. Simon GL and Gorbach SL: The human intestinal microflora. Digestive Diseases and Sciences 1986;31(9)147S-162S.
9. Simon GL and Gorbach S: Normal alimentary tract microflora, in Infections of the Gastrointestinal Tract, Ed MJ Blaiser. PD Smith, JI Ravdin. HB Greenberg and RL Guerrant. Raven Press Ltd, New York 1995:53-69.
10. Kurpad AV, Shetty PS: Effects of antimicrobial therapy of fecal bulking. Gut 1986,27:55-58.
11. Saxeeholt H, Carlstedt-Duke B, Hoverstad T, Lingaas E Norin KE, Steinbakk M and Midtvedt T: Influence of antibioticas on the faecal excretion of the bile pigments in healthy subjects. Scand J Gastroenterol 1986;21(8):991-996.
12. Bartlett JG, Condon RE, Gorbach SL, Clarke JS, Nichols RL and Ochi S: Veterans administration cooperative study on bowel preparation for selective colorectal operations: Impact of oral antibiotic regimen on colonic flora, wound irrigation cultures and bacteriology of septic complication. Ann Surg 1978;188:249-254.
13. Clarke JS, Condon RE, Bartlett JG, Gorbach SL, Nichols RL and Ochi S: Preoperative oralantibioticas reduce septic complicactions of colon operations: Results of prospective, randomized, double-blind clinical study. Ann Surg 18:251-259, 1977.
14. Brismar B, Edlund C and Nord CE: Comparative effects of clarithromycin and erythromycin on the normal intestinal microflora.Scand J Infect Dis 1991;23:635-642.
15. Stark, CA,Adamsson I, Edlund C,Sjosted S, Seensalu R Wikstrom B and Nord CE: Effects of omeprazole and amoxycillin on the human oral and gastrointestinal microflora in patients with Helicobacter pylori infection.J Antimicrob Chemother 1996;38:927-939.
16. Edlund C, Alvan G, Barkholt L, Vacheron F and Nord CE: Pharmacokinetics and comparative effects of telithromycin (HMR 3647) and clarithromycin on the oropharingeal and intestinal microflora.J Antimicrocrob Chemother 2000;46(5):741-749.
17. Adamsson I, Noerd CE, Lundquist P, Sjostedt S and Edlund C: Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patientes.J Antimicrob Chemother 199;44:629-640.
18. Buhling A, Radun D, Muller WA and Malfertheiner P: Influence af anti-Helicobacter triple-therapy with metronidazole, omeprazole and clarithromycin on intestinal microflora.Aliment Pharmacol Ther 2001;15:1445-1452.
19. Edlund C and Nord CE: A riview on the impact of 4-quinolones on the normal orophayngeal and intestinal human microflora.Infection 1988;16:8-12.
20. Nord CE: Effect of new quinolones on the human gastrointestinal microflora.Rev Inefct Dis 1988;10:S193-S196.
21. Edlund C, Nord CE: Ecological effect og gatifloxacin on the normal humen intestinal microflora. J Chemother 1999;11:50-53.
22. Edlund C, Brismar B and Nord CE: Effect of lomefloxacin on the normal oral and intestinal microflora.Eur J Clin Microbiol Infect Dis 1990;9:35-39.
23. Edlund C, Sjostedt S and Nord CE: Comparative effects of levofloxacin and ofloxacin in the normal oral and intestinal microflora.Scand J Infect is 1997;29:383-386.
24. Nord C, Movin G and Stalberg D: Impact of cefixime on the normal intestinal microflora. Scand J Infect Dis 1988;20:547-552.
25. Arvidsson A, Leijd B, Nord CE and AngelinB: Interindividual variability in biliar excretion of ceftriaxone: effects on biliary lipid metabolism and on intestinal microflora.Eur J Clin Invest 1988;18:261-266.
26. Kager L, Brismar B, Malmborg AS and Nord CE:Imipenem concentrations in colorectal surgery and impact on the colonic microflora.Antimicrob Agents Chemother 1989;33:204-208.
27. Eriksson G, Nord CE: Impact of topical metronidazole on the skin and colon microflora in patients with rosacea.Infection 1987;15:8-10.
28. Siegle RJ, Fekety R, Sarbone PD, Finch RN, Deery HG and Voorhees JJ: Effects of topical clindamycin on intestinal microflora in patients with acne. J Am Acad Dermatol 1986;15:180-185.
29. Gines P,Rimola A, Planas R, Vagas V, Marco F, Almela M, Forne M, Miranda J Salmern Jm et al.: Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology 1990;12(4 Pt1):716-724.
30. Aparicio JR, Such J, Gutierrez A, Perez-Mateo M, Plaza J and Arroyo A: Development of Escherichia coli strands resistant to quinolones in stools of patients with liver cirrhosis submitted to selective bowel decontamination Med Clin (Barc) 1999;113(7):241-245.
31. Ortiz J, Vila MC, Soriano G, Minana J, Gana J, Mirelis B, Novella MT, Coll S, Sabat M, Andreau M, Prats G, Sola R and Guarner C: Infections caused by Escheriquia coli resistant to norfloxacin in hospitaliezed cirrhotic patients. Hepatology 1999;29(4):1064-1069.